MARKET

OPHLF

OPHLF

Ono Pharmaceutic
OTCPK
16.54
NaN%
Closed 09:30 09/11 EDT
OPEN
--
PREV CLOSE
16.54
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
16.54
52 WEEK LOW
14.55
MARKET CAP
7.78B
P/E (TTM)
16.45
1D
5D
1M
3M
1Y
5Y
1D
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
TipRanks · 1d ago
Ono Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF Investors
TipRanks · 08/26 16:30
ONO Pharmaceutical Co (OPHLF) Gets a Sell from Goldman Sachs
TipRanks · 08/17 11:40
ONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
TipRanks · 08/06 16:41
ONO Pharmaceutical Q1: Record Sales, Margin Strain
TipRanks · 08/02 00:07
Ono Pharmaceutical GAAP EPS of ¥ 51.38, revenue of ¥ 116.1B
Seeking Alpha · 07/31 13:27
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
TipRanks · 07/31 03:22
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
TipRanks · 07/29 16:30
More
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.

Webull offers Ono Pharmaceutical Co Ltd stock information, including OTCPK: OPHLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPHLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPHLF stock methods without spending real money on the virtual paper trading platform.